Cancer drugs proving worth earlier in testing Daily News & Analysis The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain. With time ... The drug works for about 4 percent of advanced lung cancer patients with a mutated form of a protein called ALK ... |
